title: Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment.
authors: Dana-Farber Cancer Institute.
authors: Guillermo
authors: G
authors: de Velasco
authors: Brigham and Women's Hospital.
authors: Boonie
authors: B
authors: Bermas
authors: Dana-Farber Cancer Institute, Boston, MA.
authors: Toni K
authors: TK
authors: Choueiri
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001168:Arthritis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D001327:Autoimmune Diseases / Q000139:chemically induced*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D050823:Hand Joints / Q000000981:diagnostic imaging*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors*; D011859:Radiography; D014605:Uveitis / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab